HEAD AND NECK CANCERS
Clinical trials for HEAD AND NECK CANCERS explained in plain language.
Never miss a new study
Get alerted when new HEAD AND NECK CANCERS trials appear
Sign up with your email to follow new studies for HEAD AND NECK CANCERS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug combo targets Hard-to-Treat cancers in early trial
Disease control Recruiting nowThis study tests an experimental drug called VMD-928, taken as a pill, alone or with pembrolizumab (an immunotherapy) in adults with advanced solid tumors or lymphoma that have stopped responding to standard treatments. The goal is to find safe doses and see if the drug shrinks t…
Matched conditions: HEAD AND NECK CANCERS
Phase: PHASE1, PHASE2 • Sponsor: VM Oncology, LLC • Aim: Disease control
Last updated May 01, 2026 15:59 UTC
-
Virus therapy takes on tough tumors: first human trial launches
Disease control Recruiting nowThis early-stage study tests a new treatment called IDOV-Immune, a virus designed to infect and kill cancer cells while boosting the immune system. It is for adults with advanced solid tumors (like colorectal, lung, or breast cancer) that have not responded to standard therapies.…
Matched conditions: HEAD AND NECK CANCERS
Phase: PHASE1 • Sponsor: ViroMissile, Inc. • Aim: Disease control
Last updated May 01, 2026 15:58 UTC
-
New drug EPI-326 takes on tough cancers in first human trial
Disease control Recruiting nowThis early-phase study tests a new drug called EPI-326 in people with advanced lung cancer (with a specific EGFR mutation) or head/neck cancer. The main goals are to check safety and find the best dose. About 110 participants will receive the drug to see if it can shrink tumors a…
Matched conditions: HEAD AND NECK CANCERS
Phase: PHASE1 • Sponsor: EpiBiologics • Aim: Disease control
Last updated Apr 30, 2026 15:52 UTC
-
New drug combo shows promise for Hard-to-Treat cancers
Disease control Recruiting nowThis early-phase study tests a new drug called IDE161, alone or with another drug (pembrolizumab), in people with advanced solid tumors (like breast, ovarian, prostate, or lung cancer). The main goals are to check safety, find the best dose, and see if the drug shrinks tumors. Ab…
Matched conditions: HEAD AND NECK CANCERS
Phase: PHASE1 • Sponsor: IDEAYA Biosciences • Aim: Disease control
Last updated Apr 30, 2026 15:48 UTC
-
Sharper scans could make cancer radiation more precise
Knowledge-focused Recruiting nowThis study is testing a new type of CT scan called HyperSight, which may produce clearer images than current scans used during radiation therapy. About 50 adults with various cancers (head and neck, breast, lung, liver, or others) will receive the new scan in addition to their st…
Matched conditions: HEAD AND NECK CANCERS
Phase: NA • Sponsor: Varian, a Siemens Healthineers Company • Aim: Knowledge-focused
Last updated May 01, 2026 16:00 UTC
-
New study maps recovery journeys for head and neck cancer patients after facial rebuilding
Knowledge-focused Recruiting nowThis study aims to describe the typical care journey for 200 adults with head and neck cancer who need facial reconstruction using a bone flap from another part of the body. Researchers will analyze national health data to track hospital visits, treatments, and medications over t…
Matched conditions: HEAD AND NECK CANCERS
Sponsor: University Hospital, Toulouse • Aim: Knowledge-focused
Last updated May 01, 2026 15:58 UTC